Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 3450 of 46697 entries
View as:
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 16
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 545
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 11
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 12
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Asad Ullah Jan | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Asad Ullah Jan.temp.org | 2025-07-14 |
| Asahi Intecc USA Inc | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asahi Intecc USA Inc.temp.org | 2025-07-14 |
| Asahi Kasei Medical Co., Ltd. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Asahi Kasei Medical Co., Ltd..temp.org | 2025-07-14 |
| Asahi Kasei Pharma America Corporation | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Asahi Kasei Pharma America Corporation.temp.org | 2025-07-14 |
| Asahi Kasei Pharma Corporation | - | 16 | 0.0% | 0 | 0 | 0.0% | - | Asahi Kasei Pharma Corporation.temp.org | 2025-07-14 |
| Asalus Medical Instruments Limited | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asalus Medical Instruments Limited.temp.org | 2025-07-14 |
| Asan Foundation | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Asan Foundation.temp.org | 2025-07-14 |
| Asan Medical Center | - | 545 | 0.0% | 0 | 0 | 0.0% | - | Asan Medical Center.temp.org | 2025-07-14 |
| Asana BioSciences | - | 11 | 0.0% | 0 | 0 | 0.0% | - | Asana BioSciences.temp.org | 2025-07-14 |
| Asana Recovery | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asana Recovery.temp.org | 2025-07-14 |
| Asante Health System | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Asante Health System.temp.org | 2025-07-14 |
| Asarina Pharma | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Asarina Pharma.temp.org | 2025-07-14 |
| Asbell, Penny, M.D. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asbell, Penny, M.D..temp.org | 2025-07-14 |
| Asbestos Diseases Research Foundation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asbestos Diseases Research Foundation.temp.org | 2025-07-14 |
| Asbjorn Aroen | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Asbjorn Aroen.temp.org | 2025-07-14 |
| Asbjørn Mohr Drewes | - | 8 | 0.0% | 0 | 0 | 0.0% | - | Asbjørn Mohr Drewes.temp.org | 2025-07-14 |
| Ascelia Pharma AB | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ascelia Pharma AB.temp.org | 2025-07-14 |
| Ascend Biopharmaceuticals Ltd | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Ascend Biopharmaceuticals Ltd.temp.org | 2025-07-14 |
| Ascend Performance Materials | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ascend Performance Materials.temp.org | 2025-07-14 |
| Ascendance Biomedical | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ascendance Biomedical.temp.org | 2025-07-14 |
| Ascendis Pharma A/S | - | 12 | 0.0% | 0 | 0 | 0.0% | - | Ascendis Pharma A/S.temp.org | 2025-07-14 |
| Ascendis Pharma Bone Diseases A/S | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Ascendis Pharma Bone Diseases A/S.temp.org | 2025-07-14 |
| Ascendis Pharma Endocrinology Division A/S | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Ascendis Pharma Endocrinology Division A/S.temp.org | 2025-07-14 |
| Ascendis Pharma Growth Disorders A/S | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Ascendis Pharma Growth Disorders A/S.temp.org | 2025-07-14 |
| Ascendis Pharma Oncology Division A/S | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Ascendis Pharma Oncology Division A/S.temp.org | 2025-07-14 |